Christopher J. Kirk
CEO · Kezar Life Sciences, Inc.
Individual
- 2026
- May 11, 2026
- 1
Filings (90d)
Other insiders active in the same stocks
Insiders who have reported open-market trades at the same companies as Christopher J. Kirk. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Mark C. Schiller - $2K in KZR purchases and sales on record
- Pichi Luo Chiang - $1K in KZR purchases and sales on record
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Christopher J. Kirk?
Christopher J. Kirk is a corporate insider, tracked as CEO of Kezar Life Sciences, Inc. (KZR). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Christopher J. Kirk last file a Form 4?
The only primary Form 4 on record is dated 11 May 2026.
